http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9138424-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_916075766043ce900399a4c2eee9f054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5c2d6a5a07914730d77e365aec0bf14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-405
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405
filingDate 2013-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd43b3e96779f8722181ea5142ed428d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_893281774a9bf9f163a42cfb09e0dee5
publicationDate 2015-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9138424-B2
titleOfInvention Methods and compositions for treating cornelia de lange syndrome
abstract Disclosed are methods and compositions for treating subjects with Cornelia de Lange Syndrome (CdLS). Specifically disclosed are methods for using Indomethacin or Acemetacin to treat subjects with CdLS. Also disclosed are methods for identifying compounds beneficial for the treatment of CdLS using an assay based on the expression of NIPBL or NIPBL homologous or orthologous genes. Also disclosed is a method of identifying compounds beneficial for the treatment of CdLS based on administering a test compound to Drosophila lava with reduced expression of Nipbl, and determining the normalization of CdLS phenotypes.
priorityDate 2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400247

Total number of triples: 18.